Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are acute life-
threatening forms of hypoxemic respiratory failure. ALI/ARDS patients require intensive care …

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …

Surfactant therapy for acute lung injury/acute respiratory d... : Current Opinion in Critical
Care Surfactant therapy for acute lung injury/acute respiratory distress syndrome : Current …

Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

The importance of pulmonary surfactant in maintaining normal lung function, and the
observations that alterations in endogenous surfactant contribute to the lung dysfunction …

The acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a clinical
syndrome that affects both medical and surgical patients. To date, despite improved …

Objectives To outline both the preclinical and clinical data demonstrating surfactant
alterations in acute lung injury, which provide the rationale for testing exogenous surfactant …

Rationale: Microvascular injury, inflammation, and coagulation play critical roles in the
pathogenesis of acute lung injury (ALI). Plasma protein C levels are decreased in patients …

The acute respiratory distress syndrome (ARDS) arises from direct and indirect injury to the
lungs and results in a life-threatening form of respiratory failure in a heterogeneous, critically …

Acute respiratory distress syndrome (ARDS), is characterised by capillary permeability and
pulmonary oedema formation and may complicate a variety of medical and surgical …